Skip to main content
Cloudy with a chance of platelets: forecasting chronic ITP.
A Dried Platelet-Derived Biologic for Blood-Brain Barrier Repair and Hemorrhage Control Following TBI in Mice.
Nonmyeloablative Conditioning Combined with Anti-CD117 Antibody Briquilimab in Older Adults with High-Risk AML and MDS.
Therapy by omission: observation as a strategy in JMML.
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML.
Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia.
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Venous Thromboembolism in Individuals with Sickle Cell Disease- a Retrospective Review of This Understudied Problem
Primary Care Screening for Von Willebrand Disease in African American Adolescents with Heavy Menstrual Bleeding
Motivations and Experiences of Physicians Who Pursued Hemostasis and Thrombosis Fellowship - a Survey Study